Journal of Applied Humanities Studies
December 19, 2023
Mayura RadaKhet
This study focuses on analyzing the integration of Buddhist principles with mental health care in Thai hospitals through literature review and document analysis. The study found that Buddhist principles can significantly enhance the effectiveness of mental health treatment in hospitals. The application of mindfulness, the Four Noble Truths, and the Noble Eightfold Path in treating mental health...
Journal of Clinical Medicine
December 19, 2023
Hayley Smithers-Sheedy, Emma Waight, Katherine L Swinburn et al.
4 citations
Mindfulness-Based Stress Reduction (MBSR) has not yet been evaluated for people with cerebral palsy (CP). The aims of this randomised control trial were to investigate whether a modified telehealth MBSR program could improve mindfulness and reduce depression, anxiety, and emotion regulation difficulties among adults with CP with elevated anxiety and/or emotional regulation difficulties....
The Management of Metastatic Triple-Negative Breast Cancer: An Integrated and Expeditionary Approach
December 18, 2023
Katarzyna Rygiel
Mindfulness and compassion meditation have a positive impact on cognition, mood, behavior, and general health, based on recent studies in neuroscience. However, the research methodology is still insufficient to determine and measure different mental states during meditation, especially in minority populations. Intersectional Neuroscience, which is an innovative research model, may provide some...
Scientific Reports
December 13, 2023
Guy W. Fincham, Clara Strauss, Kate Cavanagh
Breathwork may offer simple tools for stress resilience. We conducted the largest parallel randomised-controlled trial on breathwork to date (NCT05676658) wherein 400 participants on the research platform Prolific were randomised, in blocks of 2 via remote software, to coherent breathing at ~ 5.5 breaths/min or a matched attention-placebo at 12 breaths/min, for ~ 10 min/day over 4 weeks....
bioRxiv (Cold Spring Harbor Laboratory)
December 13, 2023
Kyna‐anne Conn, Lk Milton, Kaixin Huang et al.
6 citations
preprint
Abstract Psilocybin has shown promise for alleviating symptoms of depression and is currently in clinical trials for the treatment of anorexia nervosa (AN), a condition that is characterised by persistent cognitive inflexibility. Considering that enhanced cognitive flexibility after psilocybin treatment is reported to occur in individuals with depression, it is plausible that psilocybin could...
Psychedelic Medicine
December 13, 2023
Nicholas A. Carlisle, Haley Maria Dourron, Sarah Maccarthy et al.
12 citations
Recent trials of psychedelic-assisted therapy have suggested potential efficacy for the treatment of many health conditions that disproportionately impact sexual and gender minority (SGM) people, including major depressive disorder and alcohol and tobacco use disorders. Despite these promising findings, the potential benefits of psychedelics for SGM people have been largely ignored. First, we...
The Brown University Child and Adolescent Behavior Letter
December 11, 2023
Anne S. Walters
In the last 10 years, mindfulness has become a popular approach for managing strong or distressing feelings for adults and children. Particularly for children, mindfulness‐based interventions (MBIs) have been touted as a modality for the treatment of conditions ranging from attention‐deficit hyperactivity disorder (ADHD) to anxiety, autism spectrum disorders, depression, and stress. Jon...
Medical Writing
December 11, 2023
Ivana Turek
1 citation
Research on psychotropics is gaining more popularity worldwide and support from drug regulatory agencies, which recognise the unmet medical needs of certain patient communities, such as patients with mental disorders and patients with cancer who experience depression. Cannabinoids and psilocybin have shown promising results in preclinical studies and clinical trials, but the current clinical...
Biochemistry and Biophysics Reports
December 8, 2023
Parisa Jahani Bahnamiri, Akbar Hajizadeh Moghaddam, Mojtaba Ranjbar et al.
3 citations
Cyanobacterium Nostoc commune has long been used to alleviate various diseases. This research examines the effects of Nostoc commune extract (NCE) against behavioral disorders, cerebral oxidative stress, and inflammatory damage in the ketamine-induced schizophrenia model. Oral NCE administration (70 and 150 mg/kg/d) is performed after intraperitoneal ketamine injection (20 mg/kg) for 14...
ACS Pharmacology & Translational Science
December 8, 2023
Richard A Glennon, Mal Gorzata Dukat
3 citations
α-Ethyltryptamine (AET) is quite an interesting, but perhaps long-forgotten, centrally acting agent. Known for more than 75 years, AET was once clinically available as an antidepressant but was withdrawn shortly after its introduction. AET was subsequently controlled as a U.S. Schedule I substance due to its perceived abuse liability and/or toxicity but remains an agent of interest....